BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 185234)

  • 1. Periodic remission in Cushing's disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis.
    Liberman B; Wajchenberg BL; Tambascia MA; Mesquita CH
    J Clin Endocrinol Metab; 1976 Oct; 43(4):913-8. PubMed ID: 185234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.
    Brown RD; Van Loon GR; Orth DN; Liddle GW
    J Clin Endocrinol Metab; 1973 Mar; 36(3):445-51. PubMed ID: 4346603
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N; Suda T; Aiba M; Naruse M; Nomura K; Imamura M; Demura H
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of hypothalamic-pituitary-adrenocortical function tests in patients with Cushing's syndrome.
    Hashimoto K
    Acta Med Okayama; 1975 Apr; 29(2):111-26. PubMed ID: 169671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclical Cushing's disease: two distinct rhythms in a patient with a basophil adenoma.
    Atkinson AB; Chestnutt A; Crothers E; Woods R; Weaver JA; Kennedy L; Sheridan B
    J Clin Endocrinol Metab; 1985 Feb; 60(2):328-32. PubMed ID: 2981244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anomalous response to metyrapone in Cushing's syndrome due to adrenocortical adenoma.
    Pennington LF; Kreisberg RA; Hershman JM
    J Clin Endocrinol Metab; 1970 Jan; 30(1):125-7. PubMed ID: 4311614
    [No Abstract]   [Full Text] [Related]  

  • 8. Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.
    Streeten DH; Anderson GH; Dalakos TG; Seeley D; Mallov JS; Eusebio R; Sunderlin FS; Badawy SZ; King RB
    Endocr Rev; 1984; 5(3):371-94. PubMed ID: 6088218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cushing's disease cycling over ten years.
    Popovic V; Micic D; Nesovic M; Howlett T; Doniach I; Kendereski A; Djordjevic P; Manojlovic D; Micic J; Besser M
    Exp Clin Endocrinol; 1990 Nov; 96(2):143-8. PubMed ID: 1965804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
    Crystal RG; Rose LI; Jagger PI; Lauler DP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):199-203. PubMed ID: 4317343
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of ketoconazole in the treatment of Cushing's syndrome.
    Loli P; Berselli ME; Tagliaferri M
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing's disease: clinical and laboratory response to bromocriptine therapy.
    de Pinho MO; Antunes RC; Lima MB; Francalanci CC; Franco S
    J Endocrinol Invest; 1984 Dec; 7(6):585-8. PubMed ID: 6099377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission of Cushing's disease after administration of adrenocorticotropin.
    Pratt JH; Sawin CT; Melby JC
    Am J Med; 1974 Dec; 57(6):949-52. PubMed ID: 4139895
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
    Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
    Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in secretion characteristics in Cushing's disease with and without radiologically evident pituitary tumors.
    Lamberts SW; Klijn JG; de Jong FH; Birkenhäger JC
    J Endocrinol Invest; 1980; 3(3):257-62. PubMed ID: 6253556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of ACTH by cortisol in dexamethasone-nonsuppressible Cushing's disease.
    Carey RM
    N Engl J Med; 1980 Jan; 302(5):275-9. PubMed ID: 6243171
    [No Abstract]   [Full Text] [Related]  

  • 17. Cortisol-suppressible dexamethasone-nonsuppressible cyclic Cushing's disease with evidence of clinical and biochemical remission with bromocriptine.
    Mercado-Asis LB; Murayama M; Yamakita N; Morita H; Mune T; Yasuda K; Miura K
    Endocrinol Jpn; 1991 Jun; 38(3):315-24. PubMed ID: 1665413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
    Findlay JC; Sheeler LR; Engeland WC; Aron DC
    J Clin Endocrinol Metab; 1993 Jan; 76(1):189-91. PubMed ID: 8380604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Silvestrini F; D'Alonzo R
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.